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severity increases when HOA is associated with knee or hip OA 40 . As well, OA has been 122 associated with higher age-and sex-standardized CV mortality incidence ratio than expected 123 in the general population 41 . However, data remains controversial, and no increase of 124 mortality in the OA population was also reported 42 . Some authors have suggested that OA-125 related disability could explain the higher CV mortality raising the question of reciprocity 126 between OA and cardiometabolic diseases. Thus, OA induced disability which in turn 127 promotes obesity and its cardiometabolic comorbidities 43 . However, beyond this induced 128 disability, OA may be responsible for a low-grade inflammation state via a joint release of 129 inflammatory mediators into the blood stream that could in turn aggravate cardiometabolic 130 diseases such as atherosclerosis 44 . Interestingly, an independent association has recently been 131 shown between increased popliteal artery wall thickness and subsequent knee cartilage 132 degradation seen on MRI in asymptomatic and non-disabled subjects 45 .
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Inflammation in MetS and its involvement in OA 135 During the past decade, obesity and metabolic disorders have been found related to 136 systemic low-grade chronic inflammation characterized by abnormal cytokine production, 137 increased levels of acute-phase reactants and activation of a network of inflammatory 138 signalling pathways 5, 46 . Fat mass is the cornerstone of this inflammation, but diabetes, iii. Free fatty acids and the high-fat diet 234 The increased dietary fat content that characterizes the diet of industrialized countries in OA and are associated with severe tissular lesions 77 . In vitro, palmitate, a saturated free fatty acid (FFA) induced pro-inflammatory cytokines production by chondrocytes and M A N U S C R I P T
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synoviocytes via the Toll-like Receptor -4 (TLR-4) and has pro-apoptotic effects 78 . Diabetes mellitus-related OA belongs to the MetS-associated OA phenotype.
288
Hyperglycemia and insulin resistance may explain the relationship between diabetes and OA.
289
In the streptozotocin-induced diabetic rat model, characterized by a strong hyperglycemia due diseases, but obesity and type 2 diabetes are also subject to genetic susceptibility, and risk of
337
OA onset in obese subjects could be affected by common genetic factors 128, 129 . Since 2007, the single nucleotide polymorphism in the fat mass and obesity-associated (FTO) gene has M A N U S C R I P T 
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The authors have no conflict of interest for this work. • Is OA an independent risk factor for metabolic and cardiovascular diseases?
• AGEs in type 2 diabetes-related OA pathophysiology and "anti-AGE" therapies in OA
• Insulin resistance of joint cells in type 2 diabetes and obesity
• Gut microbiota in OA and especially in obese patients We hypothesize that, in the metabolic OA phenotype, several pathways and metabolic stress factors are involved: i) obesity activates chondrocytes through mechanical signals but also through adipokines (i.e. leptin and visfatin) ii) insulin resistance limits pro-anabolic effects of insulin and enhances free fatty acid (FFA) production which is also responsible for chondrocyte activation via TLR-4 iii) at endstage, diabetes mellitus induces reactive oxygen species (ROS) and cytokine production triggered by hyperglycemia and advanced glycation end products (AGE). All these stresses induce ROS and proinflammatory cytokines which both play a major role in joint inflammation, proteolytic enzymes production and subsequent cartilage degradation.
AGE: advanced glycation end products; RAGE : receptor for AGE; GLUT: glucose transporter; FFA: free fatty acid; Ob-R: receptor for leptin; TLR-4: toll-like receptor-4. 
